Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $3250.0000 (44.44%) ($2250.0000 - $3500.0000) on Wed. Oct. 24, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 14.15% (three month average) | RSI | 95 | Latest Price | $3250.0000(44.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 9.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWP(2%) IWM(2%) USO(2%) XOP(2%) | Factors Impacting CAPR price | CAPR will decline at least -7.075% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.075% (StdDev 14.15%) | Hourly BBV | 0 () | Intraday Trend | 44.4% | | | |
|
5 Day Moving Average | $2420(34.3%) | 10 Day Moving Average | $2320.77(40.04%) | 20 Day Moving Average | $2254.45(44.16%) | To recent high | 0% | To recent low | 465.2% | Market Cap | $64.017b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |